4 unknown, 3 terminated, 2 completed, 1 active not recruiting. 3 Not applicable, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Enrolling by invitation 1, Terminated 1, Unknown 1 |
| Phase 3 | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow Adenocarcinoma in Situ: new trials by email Literature Review of Adenocarcinoma in Situ trials Research Report on Adenocarcinoma in Situ
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Role of Methylation Test Triage in HPV Positive Women Methylation Test - Precancerous Cervical Lesion | Not applicable | Unknown | Obstetrics & Gynecology Hospital of Fudan University | 10000 | 2024-04-01 | 2024-04-16 |
| Primary Cervical Cancer Screening by Self-sampling HPV Test Human Papillomavirus Infection, Cervical Cancer | Active not recruiting | Peking University People's Hospital | 17875 | 2022-11-19 | 2023-12-21 | |
| Clinical Evaluation of Detection of High Risk HPV in Urine Human Papillomavirus Infection, Cervical Cancer | Unknown | Peking University People's Hospital | 1000 | 2021-09-15 | 2022-01-27 | |
| Effectiveness of Cervical Screening in Unvaccinated, Herd Effect Protected Women (HPV400) Frequent information of cytological/ HPV DNA screening results - Cervical Intraepithelial Neoplasia Grade 2/3, Adenocarcinoma in Situ | Not applicable | Enrolling by invitation | Tampere University Hospital | 14000 | 2020-06-09 | 2025-01-13 |
| Pilot Study In Vivo Confocal Microscopy Probe for Cervical Precancer In Vivo Confocal Microscopy Probe - Precancerous Condition, Cervical Cancer | Terminated | British Columbia Cancer Agency | 60 | 2019-09-01 | 2024-03-18 | |
| CT-based Radiomic Algorithm for Assisting Surgery Decision and Predicting Immunotherapy Response of NSCLC Radiomic Algorithm - Predictive Cancer Model, Lung Cancer | Unknown | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 500 | 2019-08-01 | 2020-06-30 | |
| Safety and Immunogenicity Study of V503 (GARDASIL™9, 9vHPV Vaccine) Administered to 9- to 26-Year-Old Females and Males in Vietnam (V503-017) 9vHPV vaccine - Papillomavirus Infections, Uterine Cervical Neoplasms | Phase 3 | Completed | Merck Sharp & Dohme LLC | 201 | 2018-06-29 | 2020-02-25 |
| In the Era of the HPV Vaccine, What Are The Current HPV Subtypes Contributing to High Grade Cervical Dysplasia, Adenocarcinoma in Situ, and Early Cervical Cancer? HSIL, High-Grade Squamous Intraepithelial Lesions, Adenocarcinoma in Situ | Unknown | Sunnybrook Health Sciences Centre | 100 | 2016-11-01 | 2023-11-22 | |
| A Clinical Test for the Treatment of Multifocal Lung Cancers Using Genome Sequencing Multifocal Tissue Banking - Lung Neoplasms, Carcinoma Non-small-cell Lung | Terminated | Mayo Clinic | 8 | 2016-02-11 | 2022-04-14 | |
| Treatment of Multifocal Lung Adenocarcinoma Multifocal Lung Adenocarcinoma - Lung Neoplasms, Carcinoma Non-small-cell Lung | Not applicable | Terminated | Mayo Clinic | 100 | 2013-11-06 | 2025-11-20 |
| V501 Safety and Efficacy Study in Japanese Women Aged 16 to 26 Years (V501-110) V501 - Cervical Cancer, Cervical Intraepithelial Neoplasia | Phase 4 | Completed | Merck Sharp & Dohme LLC | 1030 | 2011-11-25 | 2018-11-28 |
Uterine Cervical Neoplasms (6) · Uterine Cervical Dysplasia (5) · Squamous Intraepithelial Lesions (4) · Lung Neoplasms (3) · Papillomavirus Infections (3) · Adenocarcinoma, Bronchiolo-Alveolar (2) · Atypical Squamous Cells of the Cervix (2) · Carcinoma, Non-Small-Cell Lung (2) · Neoplasms (2) · Adenocarcinoma (1) · Carcinoma (1) · Carcinoma in Situ (1) · Condylomata Acuminata (1) · Neoplasms by Histologic Type (1)
Morphological and Microscopic Findings (11) · Pathological Conditions, Signs and Symptoms (11) · Adenocarcinoma (10) · Carcinoma (10) · Carcinoma in Situ (10) · Neoplasms by Histologic Type (10) · Neoplasms, Glandular and Epithelial (10) · Neoplasms (9) · Neoplasms by Site (9) · Female Urogenital Diseases (7) · Female Urogenital Diseases and Pregnancy Complications (7) · Genital Diseases (7) · Genital Diseases, Female (7) · Urogenital Diseases (7) · Uterine Cervical Diseases (7)
Biopsy (1) · Colposcopy (1) · Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 (1)
Mayo Clinic (2) · Merck Sharp & Dohme LLC (2) · Peking University People's Hospital (2) · British Columbia Cancer Agency (1) · Obstetrics & Gynecology Hospital of Fudan University (1) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (1) · Sunnybrook Health Sciences Centre (1) · Tampere University Hospital (1)
China (4) · Canada (2) · United States (2) · Finland (1) · Vietnam (1)
Allan Covens, MD (1) · Dennis Wigle, MD, PhD (1) · Haiyu Zhou, PhD (1) · Hanbo Cao, PhD (1) · Herui Yao, PhD (1) · Lan Zhu, Professor (1) · Long Sui, Professor (1) · Luyu Huang (1) · Marette Lee, MD (1) · Marie Christine Aubry, MD (1) · Matti Lehtinen, MD, PhD (1) · Yunfang Yu (1)
PMID 30879979, PMID 31490545, PMID 32161969, PMID 32408396, PMID 32745170, PMID 33844623, PMID 34097688, PMID 34536311, PMID 35266975, PMID 35404177, PMID 37047452, PMID 37894462, PMID 38196123, PMID 39450703, PMID 40206677
2015 (1), 2017 (1), P01CA082710 (1)